BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17720033)

  • 1. Understanding and treating "first-episode" schizophrenia.
    Weiden PJ; Buckley PF; Grody M
    Psychiatr Clin North Am; 2007 Sep; 30(3):481-510. PubMed ID: 17720033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for first-episode schizophrenia.
    Robinson DG; Woerner MG; Delman HM; Kane JM
    Schizophr Bull; 2005 Jul; 31(3):705-22. PubMed ID: 16006592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
    Wyatt RJ; Damiani LM; Henter ID
    Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study.
    Bachmann S; Bottmer C; Schroder J
    Psychopathology; 2008; 41(2):115-23. PubMed ID: 18059113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational pharmacotherapy in early psychosis.
    Remington G
    Br J Psychiatry Suppl; 2005 Aug; 48():s77-84. PubMed ID: 16055813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.
    Buckley PE; Evans D
    Postgrad Med; 2006 Sep; Spec No():5-19. PubMed ID: 17128657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-specific psychosocial interventions for first-episode schizophrenia.
    Miller R; Mason SE
    Bull Menninger Clin; 1999; 63(4):499-519. PubMed ID: 10589141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis.
    Freudenreich O; Holt DJ; Cather C; Goff DC
    Harv Rev Psychiatry; 2007; 15(5):189-211. PubMed ID: 17924256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and addressing adherence issues in schizophrenia: from theory to practice.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 14():14-9. PubMed ID: 18284273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential brain activation during facial emotion discrimination in first-episode schizophrenia.
    Reske M; Habel U; Kellermann T; Backes V; Jon Shah N; von Wilmsdorff M; Gaebel W; Zilles K; Schneider F
    J Psychiatr Res; 2009 Mar; 43(6):592-9. PubMed ID: 19056093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
    Miller BJ
    J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
    de Haan L; van Amelsvoort T; Dingemans P; Linszen D
    Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MJA practice essentials. Managing schizophrenia in the community.
    Hustig HH; Norrie PD
    Med J Aust; 1998 Feb; 168(4):186-71. PubMed ID: 9507717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia: a review.
    Schultz SH; North SW; Shields CG
    Am Fam Physician; 2007 Jun; 75(12):1821-9. PubMed ID: 17619525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting.
    Kim B; Lee SH; Choi TK; Suh S; Kim YW; Lee E; Yook KH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1231-5. PubMed ID: 18442879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.